Does addition of 13-cis-retinoic acid to interferon-alpha2a improve survival in patients with metastatic RCC?
Nat Clin Pract Urol
.
2006 Feb;3(2):82-3.
doi: 10.1038/ncpuro0410.
Author
Jens Atzpodien
1
Affiliation
1
J Atzpodien is Professor and Head of Medical Oncology at the Fachklinik Hornheide, University of Münster, Germany.
PMID:
16470206
DOI:
10.1038/ncpuro0410
No abstract available